Levocloperastine is a novel antitussive with a pharmacological profile distinct from that of the racemic DL-cloperastine. Levocloperastine with its dual mechanism of action acts on both the ...

Many doctors are quick to prescribe dangerous drugs to their patients. Unfortunately, this could lead to the user’s demise.

Relmada Therapeutics' REL-1017 (esmethadone), and Seelos Therapeutics' SLS-002, an intranasal formulation of racemic ketamine.

After hours: September 19 at 4:52 PM EDT Loading Chart for SEEL ...

Pharmacogenomics. 2012;13(2):223-231.

today announced the U.S. Food and Drug Administration (“FDA”) has accepted the Abbreviated New Drug Application (“ANDA”) for KETARX™ (racemic ketamine) to th ...